Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Five venture firms--Aisling Capital, Canaan Partners, Domain Associates, New Leaf Venture Partners, and Sofinnova Ventures--have created Durata Therapeutics to acquire Pfizer's absorbed Vicuron Pharmaceuticals subsidiary. Durata issued an undisclosed amount of stock to pay for the transaction.
Payment Includes Stock
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?